About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 799 entries already.
Entries by Max
Newsletter 17/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This is AACR 2025 week, and there’s a lot to talk about regarding new treatments for solid tumors that could potentially include prostate cancer. Studies directly focused on prostate cancer have not yet been fully revealed, but I’ve already […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Low 10-Year Prostate Cancer Mortality Across All Treatments: Long-Term CEASAR Data Reinforce Shared Decision-Making August 14, 2026
- Bipolar Androgen Therapy (BAT) State of the Art Explained by Dr. Antonarakis August 12, 2026
- Newsletter 32/2026 August 9, 2026
- Soon to Be Phase 1/2 Trial: Bria-PROS+ Receives FDA Clearance to Begin Clinical Study in Prostate Cancer August 6, 2026
